Rani Therapeutics, a clinical stage biotherapeutics company focused on the oral delivery of biologics, has initiated a Phase I study of RT-102, an oral formulation of the human parathyroid hormone analog PTH(1-34) for the treatment of osteoporosis, delivered via capsule. The first subject has been administered RT-102… Read More
Bachem, a Swiss technology company active in the fields of chemistry, biochemistry and pharmaceuticals, as well as the development and production of peptides and oligonucleotides, analyses the findings from scientific research about the relationship between ACE2 and SARS-CoV-2. Covid-19 has impacted almost everyone’s lives, whether through personal experience of infection… Read More
Clarivate has released its annual Biopharma Deals Report, which highlights emerging market trends and features detailed analysis of the key deals of 2021 and potential implications for 2022, the full extent of which can be found on clarivate.com. This year’s report finds US biotech companies raised the majority of capital… Read More
AstraZeneca’s Evusheld (tixagevimab co-packaged with cilgavimab) has been authorised by the Medicines and Healthcare products Regulatory Agency (MHRA) and is the first antibody combination for pre-exposure prophylaxis (PrEP) against Covid-19 licensed in Great Britain. The use of this medicine is for adults who are not currently… Read More
Following the launch of Protas, an organisation which was launched on January 24, 2022, DDW Editorial Assistant Megan Thomas interviews Protas Chief Executive, Professor Sir Martin Landray, an epidemiologist and physician who has over 20 years’ experience of leading large, randomised clinical trials and has most recently been leading the… Read More
CatSci, a partner for medicines development, has secured £4.5 million of investment to expedite the development and launch of what it calls its life-changing therapeutics. The company develops economically and environmentally sustainable drug manufacturing processes that enable its global pharmaceutical customers to create affordable small molecule therapeutics… Read More
Cellular therapeutics like CAR-T have revolutionised cancer treatment and hold immense promise in other areas of unmet medical need. Developing a new therapeutic cell line is no small task and requires the design and tracking of molecular tools, viral vectors, pluripotent stem cells and more. With projects spanning weeks and… Read More
Liverpool School of Tropical Medicine (LSTM) has launched a spinout, iiDiagnostics, to enable industry engagement and commercial access to the world-leading diagnostics R&D capability and facilities at LSTM – supporting the discovery and development of innovative diagnostics with the aim of saving lives globally. First steps … Read More
News round-up by DDW’s Megan Thomas for 14-18 March, 2022 New breakthroughs, results, clinical trials and research exemplify the constant and forward-moving trajectory of the drug discovery and development industry in this week’s news round up. 1. Atrogi gets go-ahead to begin Phase I study… Read More
This is the latest episode of the free DDW podcast, “Scientific data management: What does your lab need?”. It covers three narrated articles written for Volume 22, Issue 3 – Summer 2021 and Volume 22, Issue 4 – Fall 2021 of DDW. The articles are… Read More
This is the latest episode of the free narrated DDW podcast, “Scientific data management: What does your lab need?”. It covers three narrated articles written for Volume 22, Issue 3 – Summer 2021 and Volume 22, Issue 4 – Fall 2021 of DDW. The… Read More
Research from the Francis Crick Institute has revealed a key mechanism that increases tolerance to drugs amongst microbial communities. The findings could help the development of more effective antifungal treatments. Background Antimicrobial drug resistance and tolerance occurs when bacteria, viruses, fungi or parasites no… Read More
Cellular therapeutics like CAR-T have revolutionised cancer treatment and hold immense promise in other areas of unmet medical need. Developing a new therapeutic cell line is no small task and requires the design and tracking of molecular tools, viral vectors, pluripotent stem cells and more. With projects spanning weeks and… Read More
New preclinical authentic ‘live’ virus data from Washington University School of Medicine demonstrated that Evusheld (tixagevimab co-packaged with cilgavimab) retains potent neutralising activity against the emerging and highly transmissible Omicron SARS-CoV-2 BA.2 subvariant.1 The data also showed that Evusheld retains activity against Omicron BA.1 and BA.1.1.1. The findings were… Read More
DDW’s Megan Thomas spent March 1-2, 2022 at the fourth ‘CRISPR in Drug Discovery: From Targets to Therapeutics’, which took place at Babraham Research Campus in Cambridge, UK. Finding it insightful and eye-opening, she looks forward to the next event on ELRIG's agenda, ‘Research & Innovation’ at The Kings Centre… Read More
CELLINK, A BICO company, has launched BIO CELLX, a novel system that automates 3D cell culture workflows by leveraging pre-validated protocols. The platform The BIO CELLX builds upon CELLINK’s bioprinting portfolio which utilises technologies. By introducing the concept of pre-validated protocols, the platform provides… Read More
